Last reviewed · How we verify
NCT05397522
The Effects of Observer Presence and Type on Patients' Perception of Exercise After Bone Tumor Resection-A Qualitative Study
NA trial testing Supervised Exercise by a physiotherapist via face to face in Bone Cancer in 30 participants. Status unknown.
2 February 2023
Quick facts
| Lead sponsor | Istanbul Medeniyet University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 15 August 2022 |
| Primary completion | 2 February 2023 |
| Estimated completion | 2 March 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Supervised Exercise by a physiotherapist via face to face
- Supervised Exercise by a physiotherapist via video conference
Conditions studied
- Bone Cancer — all drugs for Bone Cancer →
- Tumor — all drugs for Tumor →
Sponsor
Istanbul Medeniyet University
Who can join
Adults 18 to 65, any sex, with Bone Cancer or Tumor. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary aim of the study is to investigate the effects of supervised exercise, telerehabilitation and home-based exercise on patient perception in patients who have undergone bone tumor resection. The secondary aim of the study is to identify the barriers to starting exercise in these patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05397522
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Supervised Exercise by a physiotherapist via face to face
Trials testing the same drug.
- NCT05596565 — The Effects of Observer Presence and Type on Patients' Perception of Exercise in Patients With Soft Tissue Sarcoma · NA · unknown
Other recruiting trials for Bone Cancer
Currently open trials in the same condition.
- NCT04974008 — Osteosarcoma Maintenance Therapy With OST31-164 · Phase 2 · active not recruiting
- NCT04307914 — Focused Ultrasound and RadioTHERapy for Noninvasive Palliative Pain Treatment in Patients With Bone Metastases · NA · active not recruiting
- NCT03160274 — Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions · recruiting
Other Istanbul Medeniyet University trials
Trials by the same sponsor.
- NCT07478380 — Transcutaneous pO₂ Monitoring in PICU · recruiting
- NCT07368244 — Turkish Translation and Content Validity of the Nottwil Environmental Factors Inventory (NEFI) in Persons With Spinal Co · recruiting
- NCT07179731 — Comparison of the Effects of External Oblique Intercostal Plane Block, Subcostal Transverse Abdominis Plane Block, and T · NA · not yet recruiting
- NCT07241455 — Validity of the Children's Chelsea Critical Care Physical Assessment Tool (cCPAx-TR) in Turkish Pediatric Intensive Care · completed
- NCT07426497 — Osteopathic Manual Therapy vs Ganglion Impar Block for Chronic Coccydynia · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05397522 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Istanbul Medeniyet University
- Last refreshed: 31 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05397522.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing